Dr. Peter Recknagel, a scientist with a sales instinct

I take data from the clinic to where it is needed: into PubMed, to the Notified Body and into the hands of the physician standing in front of a patient.

What has not been published does not exist, de facto.

Every hospital records huge amounts of data every day, and every manufacturer has studies that were written only for the Notified Body. Most of it never reaches a physician. Yet somewhere a senior physician is looking for exactly these results, because he has his back against the wall and wants to know what will help his patient.

That is why I tell manufacturers what many do not want to hear: publish everything, including the results that show where your product does not help. That builds more trust than any brochure.

  1. Research.

    Doctorate as a molecular biomedical scientist (PhD), research at University College London and at Jena University Hospital.

  2. Medical technology from the inside.

    Several years during my studies at an intensive care manufacturer: training materials, congresses, product management.

  3. Sales in the operating theatre.

    Market launch of new devices at heart centres in Germany. I stood in the operating theatre hundreds of times, helped care for patients on the intensive care unit and sold the device while doing so.

  4. Self-employed since 2012.

    Evidence for more than 30 medical devices and several hundred manuscripts through to peer review. I have been working with one manufacturer for 14 years.

30+

medical devices whose evidence I helped to build

364

case reports in a manufacturer's ongoing case report series, since 2015

2012

self-employed since then, with several hundred manuscripts

We know the physicians who take part.

Over the years, a network of research-minded physicians has grown, in Germany and abroad, who do research, publish and take part in studies. We bring them along when you lack sites, and we sit down with them when a consensus statement is to be developed. We engage and look after these opinion leaders for your product: they co-research, recommend the technology to others and, not infrequently, later sit on the guideline committee. Most recently I sat down at a specialist meeting with 7 physicians, and a major publication came out of it.

Dr. Peter Recknagel at a round table with 4 physicians, agreeing on a recommendation
Status week 44 · previous project status
Dr. Peter Recknagelto you · Project: retrospective study
Status week 46Example

Hello, here is the current status.

Done
  • Data from 4 sites reviewed
  • Ethics approval received
  • Methods and results in draft
Next
  • Write the discussion
  • Alignment with the co-authors
Your approval
Target journal and author orderApproveApproved

You always speak to me directly.

For us, a project is only finished when the results are published and reach physicians, the Notified Body and payers. You get the status promptly, whenever there is something to decide. Your team gives approval, and we take care of the rest.

We also take on larger projects, up to and including the initial approval of a product. In that case I lead the project as prime contractor and bring in the right specialists from my network. If you wish, I will also step into management temporarily.

Research
University College London, Jena University Hospital
Focus areas
Extracorporeal organ support, cardiology and cardiac surgery, intensive care medicine, surgery
Next talk
MEDICA, Emergency & Critical Care Forum, 17 Nov 2026
Peter on LinkedIn

When do you have to start on evidence at the latest?

Answer 18 short questions about your product. You then receive your Evidence Plan as a PDF: which building blocks must be ready by your next deadline, when you have to start at the latest, and what budget to expect.

Create your Evidence Plan Takes 4 minutes, is confidential and free of charge.
Example of the Evidence Plan result: deadline, latest start, budget range and timeline of the building blocks

This is what your result looks like (example)

Let's get to know each other.

In the evidence call, we spend 30 minutes talking about your product. You leave with a first plan, even if we do not work together afterwards.